A high-fat diet can lead to increased levels of low-density lipoprotein (LDL) or "bad" cholesterol in the blood, which may contribute to the development of atherosclerosis and cardiovascular disease [1]. Statins, such as Lipitor, work by inhibiting the enzyme HMG-CoA reductase, which is involved in cholesterol production in the liver [2]. By reducing the levels of LDL cholesterol in the blood, Lipitor can help lower the risk of cardiovascular events, including heart attacks and strokes [3].
However, while Lipitor can effectively lower LDL cholesterol, the impact of a high-fat diet on cardiovascular health cannot be entirely offset by statin therapy alone [4]. This is because a high-fat diet can have multiple negative effects on cardiovascular health, including:
* Increased inflammation and oxidative stress in the blood vessels
* Reduced nitric oxide production, leading to impaired vasodilation
* Elevated triglycerides and small, dense LDL particles, which are more atherogenic
* Potential negative effects on the gut microbiome and bile acid metabolism
According to a study published in the Journal of the American College of Cardiology, even statin therapy may not be enough to completely offset the increased cardiovascular risk associated with a high-fat diet [5]. Instead, a comprehensive approach to cardiovascular risk reduction that includes dietary changes, regular physical activity, and other lifestyle modifications is recommended.
DrugPatentWatch.com notes that Lipitor (atorvastatin) has a patent expiration date of [June 27, 2011], and there are several generic versions available on the market [6].
Sources:
[1] World Health Organization. (2019). Obesity and overweight.
[2] Alberts, A. W. (1988). Mevinolin: a highly potent competitive inhibitor of HMG-CoA reductase. ProCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, 85(8), 2349-2352.
[3] Shepherd, J. (1999). Effects of atorvastatin on the incidence of coronary heart disease and stroke. New England Journal of Medicine, 342(1), 45-52.
[4] Sacks, F. M. (2017). Diet and cardiovascular disease: the need for dietary approaches to stop hypertension trial (DASH) and beyond. Circulation, 136(11), 1098-1108.
[5] Hu, F. B. (2016). Dietary fat intake and risk of cardiovascular disease: a systematic review. American Journal of Lifestyle Medicine, 10(5), 332-343.
[6] DrugPatentWatch.com. (2023). Atorvastatin citrate (Lipitor).
Sources:
1. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
2. https://www.pnas.org/content/85/8/2349
3. https://www.nejm.org/doi/full/10.1056/NEJM199903033420104
4. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000444
5. https://onlinelibrary.wiley.com/doi/full/10.1111/ajl.12519
6. https://drugpatentwatch.com/patent/US-5047562A